235 related articles for article (PubMed ID: 21206745)
1. Identification of histone deacetylase 3 as a biomarker for tumor recurrence following liver transplantation in HBV-associated hepatocellular carcinoma.
Wu LM; Yang Z; Zhou L; Zhang F; Xie HY; Feng XW; Wu J; Zheng SS
PLoS One; 2010 Dec; 5(12):e14460. PubMed ID: 21206745
[TBL] [Abstract][Full Text] [Related]
2. HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma.
Buurman R; Sandbothe M; Schlegelberger B; Skawran B
Eur J Med Res; 2016 Jun; 21(1):26. PubMed ID: 27342975
[TBL] [Abstract][Full Text] [Related]
3. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo.
Weichert W; Röske A; Niesporek S; Noske A; Buckendahl AC; Dietel M; Gekeler V; Boehm M; Beckers T; Denkert C
Clin Cancer Res; 2008 Mar; 14(6):1669-77. PubMed ID: 18347167
[TBL] [Abstract][Full Text] [Related]
4. Combination of polymorphisms within the HDAC1 and HDAC3 gene predict tumor recurrence in hepatocellular carcinoma patients that have undergone transplant therapy.
Yang Z; Zhou L; Wu LM; Xie HY; Zhang F; Zheng SS
Clin Chem Lab Med; 2010 Dec; 48(12):1785-91. PubMed ID: 20731616
[TBL] [Abstract][Full Text] [Related]
5. HDAC1 and HDAC2 independently predict mortality in hepatocellular carcinoma by a competing risk regression model in a Southeast Asian population.
Ler SY; Leung CH; Khin LW; Lu GD; Salto-Tellez M; Hartman M; Iau PT; Yap CT; Hooi SC
Oncol Rep; 2015 Nov; 34(5):2238-50. PubMed ID: 26352599
[TBL] [Abstract][Full Text] [Related]
6. Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin.
Hayashi A; Horiuchi A; Kikuchi N; Hayashi T; Fuseya C; Suzuki A; Konishi I; Shiozawa T
Int J Cancer; 2010 Sep; 127(6):1332-46. PubMed ID: 20049841
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
[TBL] [Abstract][Full Text] [Related]
8. Coexpression of SALL4 with HDAC1 and/or HDAC2 is associated with underexpression of PTEN and poor prognosis in patients with hepatocellular carcinoma.
Wang H; Kohashi K; Yoshizumi T; Okumura Y; Tanaka Y; Shimokawa M; Iwasaki T; Aishima S; Maehara Y; Oda Y
Hum Pathol; 2017 Jun; 64():69-75. PubMed ID: 28411180
[TBL] [Abstract][Full Text] [Related]
9. A toolbox for class I HDACs reveals isoform specific roles in gene regulation and protein acetylation.
Hess L; Moos V; Lauber AA; Reiter W; Schuster M; Hartl N; Lackner D; Boenke T; Koren A; Guzzardo PM; Gundacker B; Riegler A; Vician P; Miccolo C; Leiter S; Chandrasekharan MB; Vcelkova T; Tanzer A; Jun JQ; Bradner J; Brosch G; Hartl M; Bock C; Bürckstümmer T; Kubicek S; Chiocca S; Bhaskara S; Seiser C
PLoS Genet; 2022 Aug; 18(8):e1010376. PubMed ID: 35994477
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of histone deacetylases 1, 2, 3, and 7: HDAC2 is an independent predictor of survival in HCC.
Quint K; Agaimy A; Di Fazio P; Montalbano R; Steindorf C; Jung R; Hellerbrand C; Hartmann A; Sitter H; Neureiter D; Ocker M
Virchows Arch; 2011 Aug; 459(2):129-39. PubMed ID: 21713366
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of PP2Ac predicts poor prognosis and contributes to aggressiveness in hepatocellular carcinoma.
Gong SJ; Feng XJ; Song WH; Chen JM; Wang SM; Xing DJ; Zhu MH; Zhang SH; Xu AM
Cancer Biol Ther; 2016; 17(2):151-62. PubMed ID: 26618405
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer--overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression.
Müller BM; Jana L; Kasajima A; Lehmann A; Prinzler J; Budczies J; Winzer KJ; Dietel M; Weichert W; Denkert C
BMC Cancer; 2013 Apr; 13():215. PubMed ID: 23627572
[TBL] [Abstract][Full Text] [Related]
13. Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis.
Weichert W; Röske A; Gekeler V; Beckers T; Ebert MP; Pross M; Dietel M; Denkert C; Röcken C
Lancet Oncol; 2008 Feb; 9(2):139-48. PubMed ID: 18207460
[TBL] [Abstract][Full Text] [Related]
14. Liver-intestine cadherin predicts microvascular invasion and poor prognosis of hepatitis B virus-positive hepatocellular carcinoma.
Ding ZB; Shi YH; Zhou J; Shi GM; Ke AW; Qiu SJ; Wang XY; Dai Z; Xu Y; Fan J
Cancer; 2009 Oct; 115(20):4753-65. PubMed ID: 19626651
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells.
Yoo YG; Na TY; Seo HW; Seong JK; Park CK; Shin YK; Lee MO
Oncogene; 2008 May; 27(24):3405-13. PubMed ID: 18264140
[TBL] [Abstract][Full Text] [Related]
16. Role of p63 and p73 isoforms on the cell death in patients with hepatocellular carcinoma submitted to orthotopic liver transplantation.
González R; De la Rosa ÁJ; Rufini A; Rodríguez-Hernández MA; Navarro-Villarán E; Marchal T; Pereira S; De la Mata M; Müller-Schilling M; Pascasio-Acevedo JM; Ferrer-Ríos MT; Gómez-Bravo MA; Padillo FJ; Muntané J
PLoS One; 2017; 12(3):e0174326. PubMed ID: 28350813
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological features and prediction values of HDAC1, HDAC2, HDAC3, and HDAC11 in classical Hodgkin lymphoma.
Huang R; Zhang X; Sophia S; Min Z; Liu X
Anticancer Drugs; 2018 Apr; 29(4):364-370. PubMed ID: 29481474
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of GNA14 and its tumor-suppressive role in hepatitis B virus-related hepatocellular carcinoma.
Song G; Zhu X; Xuan Z; Zhao L; Dong H; Chen J; Li Z; Song W; Jin C; Zhou M; Xie H; Zheng S; Song P
Theranostics; 2021; 11(5):2318-2333. PubMed ID: 33500727
[TBL] [Abstract][Full Text] [Related]
19. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
20. MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer.
Noh JH; Chang YG; Kim MG; Jung KH; Kim JK; Bae HJ; Eun JW; Shen Q; Kim SJ; Kwon SH; Park WS; Lee JY; Nam SW
Cancer Lett; 2013 Jul; 335(2):455-62. PubMed ID: 23499894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
